A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

被引：0
|
作者：
Ramesh K. Ramanathan
Joel Picus
Haralambos Raftopoulos
Stephen Bernard
A. Craig Lockhart
Gary Frenette
John Macdonald
Susan Melin
Daniel Berg
Frank Brescia
Howard Hochster
Allen Cohn
机构：
[1] University of Pittsburgh School of Medicine,Division of Hematology/Oncology, Department of Medicine
[2] Washington School of Medicine,Department of Internal Medicine, Division of Hematology/Oncology
[3] Columbia University Medical Center,undefined
[4] University of North Carolina,undefined
[5] Chapel Hill,undefined
[6] Vanderbilt University Medical Center,undefined
[7] Carolinas Hematology–Oncology Associates,undefined
[8] Saint Vincent’s Comprehensive Cancer Center,undefined
[9] Aptium Oncology,undefined
[10] Wake Forest University,undefined
[11] University of Iowa,undefined
[12] Medical University of South Carolina,undefined
[13] New York University School of Medicine,undefined
[14] Rocky Mountain Cancer Center,undefined
[15] UPMC Cancer Pavilion,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Colorectal cancer; Phase II; Milataxel; MAC-321; Taxanes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 458
页数：5
相关论文
共 50 条
  • [41] An open-label, phase 2 study of patritumab deruxtecan in patients with previously treated advanced/metastatic colorectal cancer
    Raghav, K.
    Yoshino, T.
    Taniguchi, H.
    Tejpar, S.
    Vogel, A.
    Wainberg, Z.
    Yamaguchi, K.
    Fakih, M.
    Pedersen, K.
    Bando, K.
    Kawakami, H.
    Beck, J.
    Kanai, M.
    Liu, Y.
    Mekan, S.
    Pudussery, G.
    Qiu, Y.
    Kopetz, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S111 - S111
  • [42] ERIBULIN MESYLATE (E7389) IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE AND A TAXANE: PHASE II NEUROPATHY DATA
    Cortes, J. A.
    Campone, M.
    Twelves, C.
    Vahdat, L. T.
    Blum, J. L.
    Rivera, R. R.
    Shuster, D. E.
    Wanders, J.
    Fang, F.
    Allison, M. A. K.
    ANNALS OF ONCOLOGY, 2008, 19 : 70 - 70
  • [43] PHASE-II STUDY OF PULSE 5-FLUORO-2'-DEOXYURIDINE AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER PATIENTS PREVIOUSLY TREATED WITH CHEMOTHERAPY
    MARSH, JC
    DURIVAGE, HJ
    DAVIS, C
    OHOLLAREN, K
    PASQUALE, DN
    SIMONICH, SA
    VOYNICK, IM
    BERTINO, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (02): : 115 - 118
  • [44] A phase II (ph2), randomized study of magrolimab with bevacizumab and FOLFIRI in previously treated patients with advanced inoperable metastatic colorectal cancer (mCRC)
    Fakih, M. G.
    Tejani, M.
    Ren, X.
    Landes, D.
    Werneke, S.
    Curtis, K. K.
    Hecht, J. R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S735 - S735
  • [45] PHASE-II TRIAL OF MITOLACTOL IN PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CANCER - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    LANZOTTI, V
    SWEET, D
    LAD, T
    KHANDEKAR, J
    STIFF, P
    JOHNSON, C
    MILLER, S
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1303 - 1304
  • [46] Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer
    Swiecicki, Paul L.
    Yilmaz, Emrullah
    Rosenberg, Ari Joseph
    Fujisawa, Takao
    Bruce, Justine Yang
    Meng, Changting
    Wozniak, Michele
    Zhao, Yongyun
    Mihm, Michael
    Kaplan, Jason
    Gorla, Seema
    Geiger, Jessica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [47] A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines
    Vici, Patrizia
    Di Lauro, Luigi
    Sergi, Domenico
    Foggi, Paolo
    Viola, Giuditta
    Mottolese, Marcella
    Giotta, Francesco
    Fattoruso, Silvia I. S.
    Corsetti, Serena
    Giannarelli, Diana
    Botti, Claudio
    Lopez, Massimo
    ONCOLOGY, 2008, 75 (3-4) : 175 - 181
  • [48] Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer
    Shields, AF
    Lange, M
    Zalupski, MM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (01): : 96 - 98
  • [49] Phase II study of trabectedin in pretreated patients with advanced colorectal cancer
    Paz-Ares, Luis
    Rivera-Herreros, Fernando
    Diaz-Rubio, Eduardo
    Garcia, Margarita
    Casado, Esther
    Cubedo, Ricardo
    Gravalos, CrIstina
    Alfaro, Vicente
    Gomez, Javier
    Angel Izquierdo, Miguel
    Tabernero, Josep
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 522 - 528
  • [50] Phase II study of eribulin mesylate (E7389) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracycline, taxane, and capecitabine therapy
    Vahdat, L. T.
    Twelves, C.
    Allison, M. K.
    Cortes, J. A.
    Campone, M.
    Shuster, D. E.
    Wanders, J.
    Fang, F.
    Gurnani, R. D.
    Blum, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345